Market Knowledge and Stakeholder Considerations for the Biopharmaceutics Sector—Incorporating User Value and Societal Needs in Therapeutic Interventions

Purpose: Many health systems are considered ill-equipped to adequately meet future demand. Although academic entrepreneurs and small medium-sized enterprises (SMEs) drive technology innovation, they often suboptimally consider important market stakeholder requirements. This can result in missed opportunities improve system performance, address demand-supply gaps, achieve financial rewards. Market intelligence provide crucial information this regard, but scientifically sourced guidance on how perform research for biopharmaceutics is scarce. Our objective was, therefore, create an easily accessible toolbox that be perused by SMEs the alignment of their developments with needs. Design: Guided orientation theory, we interviewed senior managers commercialisation experts from sector. We asked them which most relevant, collect, analyse respond new align product features, positioning stakeholder-relationship management Findings: innovator consists a high-level overview considerations mapped against novel innovation framework, reasoning value model, detailed (checklists) per interventions. Originality: here first orientation-based primarily collated SMEs, our sector help all stakeholders better understand towards markets.